The FSHD Society announced today that the U.S. Food and Drug Administration (FDA) has approved its application to hold an externally led Patient-Focused Drug Development (EL-PFDD) meeting on facioscapulohumeral muscular… Read More »
Patient-Focused Drug Development Meeting for FSHD
A coloring book for the mobility challenged
Coloring books are no longer just for kids. They are a hot trend for adults who find that coloring between the lines is a relaxing, creative outlet in our ever-more… Read More »
New genetic test being developed for FSHD
From Globe Newswire Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® system, a genome imaging platform for ultra-sensitive and ultra-specific genome-wide structural… Read More »
Tax advantages from ABLE accounts
You may not even know you are eligible for these By Chris Stenmon, CPA, Braintree, Massachusetts Some consider this the most significant federal legislation for disabled individuals since President George… Read More »
FSHD Gene May Help Tumors Evade the Immune System
BY ALEXANDRA BELAYEW, MONS, BELGIUM DUX4, the gene that plays a key role in facioscapulohumeral muscular dystrophy (FSHD), is gaining unexpected notoriety in cancer research. According to a recent study1… Read More »